Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.
作者信息
Stingeni Luca, Francisci Daniela, Bianchi Leonardo, Hansel Katharina, Tramontana Marta, Di Candilo Francesco, Mannarino Massimo Raffaele, Pirro Matteo
机构信息
Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Infectious Diseases Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
出版信息
Contact Dermatitis. 2021 Sep;85(3):366-368. doi: 10.1111/cod.13857. Epub 2021 Apr 23.
Abstract
摘要
相似文献
1
Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.
Contact Dermatitis. 2021 Sep;85(3):366-368. doi: 10.1111/cod.13857. Epub 2021 Apr 23.
2
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Am J Dermatopathol. 2021 May 1;43(5):342-348. doi: 10.1097/DAD.0000000000001819.
3
Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test.
Pediatr Dermatol. 2019 Jul;36(4):514-516. doi: 10.1111/pde.13838. Epub 2019 May 3.
4
Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Indian J Pharmacol. 2015 Nov-Dec;47(6):693-4. doi: 10.4103/0253-7613.169589.
5
Acute generalized exanthematous pustulosis induced by oxacillin confirmed by patch testing.
Contact Dermatitis. 2018 Aug;79(2):108-110. doi: 10.1111/cod.13005. Epub 2018 Apr 14.
6
Results of patch testing in acute generalized exanthematous pustulosis (AGEP): A literature review.
Contact Dermatitis. 2022 Aug;87(2):119-141. doi: 10.1111/cod.14075. Epub 2022 Mar 14.
7
AGEP sine pustulosis induced by hydroxychloroquine used for COVID-19 infection.
Dermatol Ther. 2022 Mar;35(3):e15263. doi: 10.1111/dth.15263. Epub 2021 Dec 26.
8
The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Pharmacology. 2019;104(1-2):57-59. doi: 10.1159/000500406. Epub 2019 May 8.
9
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.
10
COVID-19 presenting as acute generalized exanthematous pustulosis associated with multiorgan dysfunction in a 44-year-old female patient.
Rev Inst Med Trop Sao Paulo. 2021 May 24;63:e42. doi: 10.1590/S1678-9946202163042. eCollection 2021.
引用本文的文献
1
Acute generalized exanthematous pustulosis: a complication of COVID-19 infection or therapy?
J Cosmet Dermatol. 2022 May;21(5):1784-1787. doi: 10.1111/jocd.14930. Epub 2022 Apr 5.
2
Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.
J Clin Med. 2022 Jan 13;11(2):397. doi: 10.3390/jcm11020397.
3
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
J Cosmet Dermatol. 2021 Aug;20(8):2387-2389. doi: 10.1111/jocd.14304. Epub 2021 Jun 27.
本文引用的文献
1
Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
Am J Case Rep. 2020 Oct 24;21:e926901. doi: 10.12659/AJCR.926901.
2
Skin tests in the diagnosis of adverse drug reactions.
G Ital Dermatol Venereol. 2020 Oct;155(5):602-621. doi: 10.23736/S0392-0488.20.06698-5. Epub 2020 Sep 17.
3
Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.
J Am Acad Dermatol. 2020 Dec;83(6):1738-1748. doi: 10.1016/j.jaad.2020.08.006. Epub 2020 Aug 7.
4
Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.
Allergy. 2020 Nov;75(11):2775-2793. doi: 10.1111/all.14439. Epub 2020 Jul 1.
5
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e537-e539. doi: 10.1111/jdv.16664. Epub 2020 Jul 2.
6
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e457-e459. doi: 10.1111/jdv.16613. Epub 2020 Jul 3.
7
Cutaneous drug hypersensitivity: developments and controversies.
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):308-318. doi: 10.1097/ACI.0000000000000548.
8
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity.
Allergy. 2019 Jan;74(1):14-27. doi: 10.1111/all.13562. Epub 2018 Dec 5.
9
Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study.
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):808-810. doi: 10.1016/j.jaip.2016.10.009. Epub 2016 Dec 4.
10
A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.
Br J Dermatol. 2013 Mar;168(3):555-62. doi: 10.1111/bjd.12125.
Zotero 插件